American Association of Individual Investors6d
Which Is a Better Investment, Recursion Pharmaceuticals, Inc. or Veracyte, Inc. Stock?
Learn more about whether Recursion Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
IFP Advisors Inc Purchases 7,455 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
IFP Advisors Inc lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 170.4% in the 4th ...
Leerink Partners Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $6.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) had its target price dropped by Leerink Partners from $7.00 to $6.00 in a note issued to investors on Friday,Benzinga reports. The brokerage ...
Frontiers13d
Diabetic kidney disease: m6A modification as a marker of disease progression and subtype classification
AXIN1 and GOLGA4 are potential biomarkers for targeted therapy. We comprehensively evaluated the potential regulatory mechanisms of m6A modification in the progression of DKD, providing new insights ...
Frontiers20d
Exploring the potential anti-senescence effects of soybean-derived peptide Soymetide in mice hippocampal neurons via the Wnt/β-catenin pathway
Research indicates that Wnt signaling influences cellular senescence, and our findings here demonstrate that doxorubicin decreased hippocampal Wnt3a, p-LRP6, Frizzled, Dishevelled, Axin1, and ...
ascopubs.org9d
Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid Tumors
Toward Functional Biomarkers of Response to Neoadjuvant Oncolytic Virus in Stage II Melanoma: Immune-Förster Resonance Energy Transfer and the Dynamic Tumor Immune Microenvironment This retrospective ...